In response to inflammatory stimuli, neutrophils (PMN) remodel cell membranes to generate bioactive lipid-derived signals that serve as intra- or extracellular mediators for the transduction of functional responses. We recently identified polyisoprenyl phosphates (PIPP) as novel, intracellular counter- regulatory signals in PMN. One of these PIPP's, presqualene diphosphate (PSDP), is present in unstimulated cells and, upon cell stimulation, undergoes rapid dephosphorylation with a reciprocal increase in its monophosphate form, PSMP, PSDP, but not PSMP or closely related compounds, inhibits agonist-induced superoxide anion generation and phospholipase D (PLD). Here, the proposed experiments will test the hypothesis that polyisoprenyl phosphates are novel intracellular signals that counteract processes initiated by phosphoinositide signaling. The scientific community has become accustomed to thinking of receptor-ligand interacts as leading to the rapid elaboration of pro-inflammatory intracellular signals, such as phosphoinositol biphosphate (PIP2) and phosphoinositol trisphosphate (PIPS). It is also possible that counter-regulatory lipid signals (e.g., PSDP) are held at a set point in resting cells to provide regulated negative signaling that is rapidly decreased upon cell stimulation. This new paradigm would introduce the notion that inflammatory responses may result, in part, from the release of biochemical """"""""brakes"""""""" rather than activation of biochemical """"""""accelerators."""""""" To test our hypothesis, we propose three specific aims: 1. determine the key domains and residues in PLD responsible for inhibition by PSDP. 2. determine the relationship between PIPP and phosphoinositide turnover during human PMN stimulation, and 3. elucidate a novel phosphatase responsible for PIPP remodeling during PMN stimulation. From my clinical training as a pulmonologist, I became acutely aware of our incomplete understanding of the pathobiology of pulmonary inflammation. As a new investigator, I am firmly committed to the pursuit of pivotal regulatory mechanisms for pulmonary inflammation. The long-term objectives are two-fold: (i) identify a basis for new interventional strategies that promote resolution of inflammatory responses and (ii) elucidate the role of lipid mediators in respiratory diseases of elderly individuals.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Croxton, Thomas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Abdulnour, R E; Sham, H P; Douda, D N et al. (2016) Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. Mucosal Immunol 9:1278-87
Awji, Elias G; Chand, Hitendra; Bruse, Shannon et al. (2015) Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol 52:377-86
Karra, L; Haworth, O; Priluck, R et al. (2015) Lipoxin B? promotes the resolution of allergic inflammation in the upper and lower airways of mice. Mucosal Immunol 8:852-62
Doyle, Jamie R; Krishnaji, Subrahmanian T; Zhu, Guangli et al. (2014) Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain. J Biol Chem 289:13385-96
Levy, Bruce D; Serhan, Charles N (2014) Resolution of acute inflammation in the lung. Annu Rev Physiol 76:467-92
Abdulnour, Raja-Elie E; Dalli, Jesmond; Colby, Jennifer K et al. (2014) Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci U S A 111:16526-31
Serhan, Charles N; Chiang, Nan; Dalli, Jesmond et al. (2014) Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 7:a016311
Li, Chenggang; Lee, Po-Shun; Sun, Yang et al. (2014) Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med 211:15-28
Bozinovski, Steven; Anthony, Desiree; Anderson, Gary P et al. (2013) Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways. Pharmacol Ther 140:280-9
Barnig, Cindy; Cernadas, Manuela; Dutile, Stefanie et al. (2013) Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5:174ra26

Showing the most recent 10 out of 38 publications